Blood Glucose Monitoring Nursing Guide 2026: Hypoglycemia, Hyperglycemia, Insulin Administration, and ICU Glucose Management

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

This article was created with AI assistance.

Blood glucose dysregulation is present in the majority of hospitalized patients — including many without a diabetes diagnosis. Hyperglycemia from stress response affects surgical patients, critically ill patients, and patients on high-dose corticosteroids regardless of prior diabetes history. Hypoglycemia from insulin administration is one of the most common and preventable serious medication errors in inpatient nursing. Competent blood glucose management is one of the most frequently practiced clinical skills across all inpatient nursing settings.

Normal Blood Glucose Ranges

Context	Target Range	Notes
Fasting (non-diabetic, non-ICU)	70–99 mg/dL	Normal fasting glucose; prediabetes defined as 100–125; diabetes defined as 126+ on two occasions
Postprandial (2 hours after eating)	<140 mg/dL (non-diabetic)	140–199 = impaired glucose tolerance; 200+ with symptoms = diabetes criteria met
General inpatient (non-critical)	140–180 mg/dL	ADA/AACE inpatient target; tighter targets in selected patients at provider discretion
ICU (critically ill)	140–180 mg/dL	NICE-SUGAR trial (2009) showed tight glycemic control (81–108) in ICU increased mortality — moderate control is now standard. Some protocols target 110–150 depending on institution and patient
Hypoglycemia threshold	<70 mg/dL	ADA definition; clinically significant hypoglycemia = <54 mg/dL; severe hypoglycemia = altered consciousness, seizure, or loss of consciousness

Blood Glucose Monitoring: Technique and Timing

Glucometer technique: Wash hands before obtaining the finger-stick sample (alcohol wipes may temporarily affect reading accuracy if not fully dried). Use the lateral aspects of the fingertips (less pain, better perfusion) rather than the fingertip pad. Avoid cold fingers — warm the hand first if circulation is poor, as cold peripheral blood may give falsely low readings. Discard the first drop of blood (may contain interstitial fluid that dilutes the sample); use the second drop. Apply blood to the test strip promptly and per the meter manufacturer's instructions.

Glucometer limitations: Point-of-care glucose meters are accurate within ±15–20% of laboratory glucose values in most cases, but this margin of error has clinical significance at the extremes. A meter reading of 65 mg/dL could reflect a true glucose of 50–80 mg/dL. For critical clinical decisions (insulin drip titration, treatment of severe hypoglycemia), a laboratory plasma glucose is more reliable than a bedside glucometer. Glucometers are also unreliable in patients with severe anemia, polycythemia, or extremes of hematocrit.

Monitoring frequency: Varies by patient situation and institutional protocol. Typical examples: pre-meal and bedtime for most diabetic patients on insulin; every 1–2 hours for patients on continuous insulin infusions; every 4–6 hours for NPO patients on sliding scale; every 1–2 hours during hypoglycemia treatment until glucose is confirmed above 70 mg/dL for two consecutive checks.

Hypoglycemia: Recognition and Management

Signs and Symptoms

Adrenergic (early, typically 50–70 mg/dL): Tremors, diaphoresis, tachycardia, anxiety, pallor, hunger, nausea — symptoms from epinephrine/glucagon release as the body attempts to raise glucose. These symptoms allow the patient to self-recognize and self-treat if alert.

Neuroglycopenic (later, typically below 50 mg/dL): Confusion, difficulty concentrating, altered mental status, slurred speech, visual changes, personality changes, seizures, loss of consciousness — symptoms from inadequate glucose delivery to the brain. Patients cannot reliably self-treat at this stage. Important: Patients on beta-blockers may have blunted adrenergic symptoms and present with neuroglycopenic symptoms without the classic early warning signs.

The Rule of 15

For conscious patients with blood glucose 54–70 mg/dL who can swallow safely:

Give 15 grams of fast-acting carbohydrates. Examples: 4 oz (120 mL) of fruit juice; 4 oz regular (not diet) soda; 3–4 glucose tablets; 15 mL (1 tablespoon) of honey or corn syrup; glucose gel per package directions.

Wait 15 minutes, then recheck blood glucose.

If still below 70 mg/dL, repeat 15 grams of fast-acting carbohydrate and recheck in another 15 minutes.

Once glucose is above 70 mg/dL and the next meal is more than 1 hour away, give a small snack containing protein and complex carbohydrate to prevent rebound hypoglycemia.

Hypoglycemia in the Unconscious or NPO Patient

If the patient cannot swallow safely: call the provider immediately and prepare to administer IV dextrose per order. D50W (50% dextrose, 25 grams dextrose in 50 mL) is the rapid IV treatment. Administer through a large, patent peripheral IV or central line — D50W is highly concentrated and causes significant vein irritation; confirm patency before administration. In the ICU or for patients without IV access, glucagon 1 mg IM/SQ may be administered (stimulates hepatic glycogen release; less effective in patients with liver disease or prolonged fasting). Recheck glucose 15 minutes after IV dextrose administration.

Notify the provider immediately for: Blood glucose below 54 mg/dL; any hypoglycemia in an unconscious patient; hypoglycemia requiring more than two treatment cycles to resolve; hypoglycemia in a patient receiving continuous IV insulin (adjust infusion rate per protocol); recurrent hypoglycemia (two or more episodes in 24 hours — indicates need for insulin regimen adjustment, not just treatment of individual episodes).

Hyperglycemia Management

Insulin Types: Onset, Peak, and Duration

Insulin Type	Examples	Onset	Peak	Duration	Clinical Use
Rapid-acting	Lispro (Humalog), Aspart (NovoLog), Glulisine (Apidra)	10–15 min	1–2 hrs	3–5 hrs	Given immediately before or at start of meal; covers postprandial glucose rise; also used in insulin pumps
Short-acting (regular)	Regular insulin (Humulin R, Novolin R)	30–60 min	2–3 hrs	5–8 hrs	Mealtime coverage (give 30 min before meal); IV insulin infusions in ICU; sliding scale correction; DKA treatment IV
Intermediate-acting	NPH (Humulin N, Novolin N)	1–2 hrs	4–6 hrs	10–16 hrs	Basal coverage; typically given twice daily; less commonly used since long-acting analogs became available
Long-acting	Glargine (Lantus, Basaglar), Detemir (Levemir), Degludec (Tresiba)	1–2 hrs	Relatively flat (minimal peak)	20–24+ hrs	Basal insulin; given once or twice daily for background coverage; do NOT mix with other insulins; continue through hospitalization unless eating is severely impaired

LASA insulin safety: Insulin is a high-alert medication (ISMP high-alert drug list). Look-alike/sound-alike insulin errors have caused deaths. Humalog (lispro) and Humulin (regular) are commonly confused. Always confirm: correct insulin name, correct concentration (U-100 standard; U-200 and U-500 concentrations also available — require careful dose calculation), correct route (subcutaneous vs. IV — only regular insulin is administered IV). Have a second nurse verify insulin dose and type before administration per facility policy.

Blood Glucose Targets in Specific Situations

DKA (Diabetic Ketoacidosis): Initial target is NOT normoglycemia — it is stopping ketone production. IV regular insulin infusion typically runs until the anion gap closes, even if glucose falls below 250 mg/dL. When glucose drops to 200–250 mg/dL during DKA treatment, D5W is added to the IV to maintain the insulin infusion without causing hypoglycemia while ketoacidosis continues to resolve. The insulin infusion is transitioned to subcutaneous insulin only after anion gap closes and patient can eat.

HHS (Hyperosmolar Hyperglycemic State): Very high glucose (often above 600 mg/dL) without significant ketoacidosis. Treatment focuses on aggressive fluid resuscitation first, then cautious insulin administration. Glucose should not be corrected faster than 50–75 mg/dL/hour — rapid correction risks cerebral edema.

Corticosteroid-induced hyperglycemia: Common pattern: glucose rises in the afternoon/evening (following morning prednisone dose) while fasting morning glucose may be near-normal. Insulin regimen should be timed to address the peak hyperglycemia period, not just fasting coverage. Patients discharged on steroids often need temporary insulin prescriptions.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.